Growth hormone alters the glutathione S-transferase and mitochondrial thioredoxin systems in long-living ames dwarf mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 10, 2014, Pages 1199-1211

  Rojanathammanee, Lalida ^a,b   Rakoczy, Sharlene ^a   Brown Borg, Holly M ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

Author keywords

Ames dwarf mice; Glutaredoxin; Glutathione S transferase; Growth hormone; Stress resistance

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; GROWTH HORMONE; THIOREDOXIN;

ANIMAL; DWARFISM; LONGEVITY; METABOLISM; MITOCHONDRION; MOUSE;

ANIMALS; DWARFISM; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GROWTH HORMONE; LONGEVITY; MICE; MITOCHONDRIA; THIOREDOXINS;

EID: 84922256803     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt178     Document Type: Article

References (99)

1. Bartke A. Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size. Results Probl Cell Differ. 2000;29:181-202.
2. Sornson MW, Wu W, Dasen JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature. 1996;384:327-333.
3. Chandrashekar V, Bartke A. Induction of endogenous insulin-like growth factor-I secretion alters the hypothalamic-pituitary-testicular function in growth hormone-deficient adult dwarf mice. Biol Reprod. 1993;48:544-551.
4. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33.
5. Brown-Borg HM. Hormonal control of aging in rodents: the somatotropic axis. Mol Cell Endocrinol. 2009;299:64-71.
6. Brown-Borg HM, Rakoczy SG. Catalase expression in delayed and premature aging mouse models. Exp Gerontol. 2000;35:199-212.
7. Hauck SJ, Bartke A. Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase.free Radic Biol Med. 2000;28:970-978.
8. Brown-Borg HM, Rakoczy SG, Romanick MA, Kennedy MA. Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Exp Biol Med (Maywood). 2002;227:94-104.
9. Raza H, Robin MA, Fang JK, Avadhani NG. Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress. Biochem J. 2002;366(Pt 1):45-55.
10. Raza H, Avadhani NG. Hepatic mitochondrial cytochrome P-450 system. Purification and characterization of two distinct forms of mitochondrial cytochrome P-450 from beta-naphthoflavone-induced rat liver. J Biol Chem. 1988;263:9533-9541.
11. Cheng JZ, Singhal SS, Sharma A, et al. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch Biochem Biophys. 2001;392:197-207.
12. Toba G, Aigaki T. Disruption of the microsomal glutathione S-transferase-like gene reduces life span of Drosophila melanogaster. Gene. 2000;253:179-187.
13. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol toxicol. 2005;45:51-88.
14. Yoshitake S, Nanri H, Fernando MR, Minakami S. Possible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J Biochem. 1994;116:42-46.
15. Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress.free Radic Res. 1995;22:193-207.
16. Jowsey IR, Thomson RE, Orton TC, Elcombe CR, Hayes JD. Biochemical and genetic characterization of a murine class Kappa glutathione S-transferase. Biochem J. 2003;373(Pt 2):559-569.
17. Singh SP, Janecki AJ, Srivastava SK, et al. Membrane association of glutathione S-transferase mGSTA4-4, an enzyme that metabolizes lipid peroxidation products. J Biol Chem. 2002;277:4232-4239.
18. Gardner JL, Gallagher EP. Development of a peptide antibody specific to human glutathione S-transferase alpha 4-4 (hGSTA4-4) reveals preferential localization in human liver mitochondria. Arch Biochem Biophys. 2001;390:19-27.
19. Prabhu KS, Reddy PV, Gumpricht E, et al. Microsomal glutathione S-transferase A1-1 with glutathione peroxidase activity from sheep liver: molecular cloning, expression and characterization. Biochem J. 2001;360(Pt 2):345-354.
20. Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem Pharmacol. 1998;56:831-839.
21. Mannervik B, Danielson UH. Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem. 1988;23:283-337.
22. Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P. Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry. 2008;47:3900-3911.
23. Srivastava PK, Waxman DJ. Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver. Biochem J. 1993;294(Pt 1):159-165.
24. Staffas L, Ellis EM, Hayes JD, Lundgren B, Depierre JW, Mankowitz L. Growth hormone- and testosterone-dependent regulation of glutathione transferase subunit A5 in rat liver. Biochem J. 1998;332(Pt 3):763-768.
25. Staffas L, Mankowitz L, Söderström M, et al. Further characterization of hormonal regulation of glutathione transferase in rat liver and adrenal glands. Sex differences and demonstration that growth hormone regulates the hepatic levels. Biochem J. 1992;286(Pt 1):65-72.
26. Brown-Borg HM, Rakoczy SG, Uthus EO. Growth hormone alters methionine and glutathione metabolism in Ames dwarf mice. Mech Ageing Dev. 2005;126:389-398.
27. Miller RA, Chang Y, Galecki AT, Al-Regaiey K, Kopchick JJ, Bartke A. Gene expression patterns in calorically restricted mice: partial overlap with long-lived mutant mice. Mol Endocrinol. 2002;16:2657-2666.
28. Amador-Noguez D, Yagi K, Venable S, Darlington G. Gene expression profile of long-lived Ames dwarf mice and Little mice. Aging Cell. 2004;3:423-441.
29. Tsuchiya T, Dhahbi JM, Cui X, Mote PL, Bartke A, Spindler SR. Additive regulation of hepatic gene expression by dwarfism and caloric restriction. Physiol Genomics. 2004;17:307-315.
30. Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun. 2010;396:120-124.
31. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem. 1989;264:13963-13966.
32. Holmgren A. Thioredoxin. Annu Rev Biochem. 1985;54:237-271.
33. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct. 2001;30:421-455.
34. Lillig CH, Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid Redox Signal. 2007;9:25-47.
35. Yoshida T, Oka S, Masutani H, Nakamura H, Yodoi J. The role of thioredoxin in the aging process: involvement of oxidative stress. Antioxid Redox Signal. 2003;5:563-570.
36. Lee S, Kim SM, Lee RT. Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid Redox Signal. 2013;18:1165-1207.
37. Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem. 1997;272:2936-2941.
38. Arnér ES. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta. 2009;1790:495-526.
39. Aslund F, Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell. 1999;96:751-753.
40. Lundberg M, Johansson C, Chandra J, et al. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem. 2001;276:26269-26275.
41. Gladyshev VN, Liu A, Novoselov SV, et al. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem. 2001;276:30374-30380.
42. Berndt C, Lillig CH, Holmgren A. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta. 2008;1783:641-650.
43. Bushweller JH, Aslund F, Wüthrich K, Holmgren A. Structural and functional characterization of the mutant Escherichia coli glutaredoxin (C14-S) and its mixed disulfide with glutathione. Biochemistry. 1992;31:9288-9293.
44. Fernandes AP, Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal. 2004;6:63-74.
45. Habig WH, Jakoby WB. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 1981;77:398-405.
46. Mannervik B, Castro VM, Danielson UH, Tahir MK, Hansson J, Ringborg U. Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis. 1987;8:1929-1932.
47. Robin MA, Prabu SK, Raza H, Anandatheerthavarada HK, Avadhani NG. Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70. J Biol Chem. 2003;278:18960-18970.
48. Holmgren A. Glutathione-dependent synthesis of deoxyribonucleotides. Characterization of the enzymatic mechanism of Escherichia coli glutaredoxin. J Biol Chem. 1979;254:3672-3678.
49. Luthman M, Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry. 1982;21:6628-6633.
50. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995;252:199-208.
51. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
52. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90:7915-7922.
53. Stadtman ER, Starke-Reed PE, Oliver CN, Carney JM, Floyd RA. Protein modification in aging. ExS. 1992;62:64-72.
54. Warner HR. Superoxide dismutase, aging, and degenerative disease.free Radic Biol Med. 1994;17:249-258.
55. Sohal RS, Orr WC. Relationship between antioxidants, prooxidants, and the aging process. Ann N Y Acad Sci. 1992;663:74-84.
56. Bohr VA, Anson RM. DNA damage, mutation and fine structure DNA repair in aging. Mutat Res. 1995;338:25-34.
57. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem. 1987;262:5488-5491.
58. Stadtman ER. Biochemical markers of aging. Exp Gerontol. 1988;23:327-347.
59. Sohal RS, Dubey A. Mitochondrial oxidative damage, hydrogen peroxide release, and aging.free Radic Biol Med. 1994;16:621-626.
60. Van Heemst D, Beekman M, Mooijaart SP, et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell. 2005;4:79-85.
61. Honda Y, Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. fASEB J. 1999;13:1385-1393.
62. Ishii N, Goto S, Hartman PS. Protein oxidation during aging of the nematode Caenorhabditis elegans.free Radic Biol Med. 2002;33:1021-1025.
63. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19:717-797.
64. Brown-Borg HM, Bode AM, Bartke A. Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine. 1999;11:41-48.
65. Brown-Borg HM, Rakoczy SG. Growth hormone administration to long-living dwarf mice alters multiple components of the antioxidative defense system. Mech Ageing Dev. 2003;124:1013-1024.
66. Brown-Borg HM, Rakoczy SG. Glutathione metabolism in long-living Ames dwarf mice. Exp Gerontol. 2005;40:115-120.
67. Brown-Borg HM. Hormonal regulation of longevity in mammals. Ageing Res Rev. 2007;6:28-45.
68. Salmon AB, Murakami S, Bartke A, Kopchick J, Yasumura K, Miller RA. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am J Physiol Endocrinol Metab. 2005;289:E23-E29.
69. Bokov AF, Lindsey ML, Khodr C, Sabia MR, Richardson A. Longlived Ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci. 2009;64:819-827.
70. Pulford DJ, Hayes JD. Characterization of the rat glutathione S-transferase Yc2 subunit gene, GSTA5: identification of a putative antioxidant-responsive element in the 5, -flanking region of rat GSTA5 that may mediate chemoprotection against aflatoxin B1. Biochem J. 1996;318(Pt 1):75-84.
71. Coecke S, Vanhaecke T, Foriers A, et al. Hormonal regulation of glutathione S-transferase expression in co-cultured adult rat hepatocytes. J Endocrinol. 2000;166:363-371.
72. Xia C, Hu J, Ketterer B, Taylor JB. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J. 1996;313(Pt 1):155-161.
73. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol. 1990;137:845-853.
74. Sundberg AG, Nilsson R, Appelkvist EL, Dallner G. Immunohistochemical localization of alpha and pi class glutathione transferases in normal human tissues. Pharmacol toxicol. 1993;72:321-331.
75. Blackburn AC, Matthaei KI, Lim C, et al. Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol. 2006;69:650-657.
76. Brandoni A, Torres AM. Characterization of the mechanisms involved in the increased renal elimination of bromosulfophthalein during cholestasis: involvement of Oatp1. J histochem Cytochem. 2009;57:449-456.
77. Schwarz LR, Summer KH, Schwenk M. Transport and metabolism of bromosulfophthalein by isolated rat liver cells. Eur J Biochem. 1979;94:617-622.
78. Choksi KB, Roberts LJ 2nd, De Ford JH, Rabek JP, Papaconstantinou J. Lower levels of F2-isoprostanes in serum and livers of long-lived Ames dwarf mice. Biochem Biophys Res Commun. 2007;364:761-764.
79. Baker A, Santos BD, Powis G. Redox control of caspase-3 activity by thioredoxin and other reduced proteins. Biochem Biophys Res Commun. 2000;268:78-81.
80. Powis G, Mustacich D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer.free Radic Biol Med. 2000;29:312-322.
81. Nakamura H, Masutani H, Yodoi J. Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. Semin Cancer Biol. 2006;16:444-451.
82. Urig S, Becker K. On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol. 2006;16:452-465.
83. Li C, Thompson MA, Tamayo AT, et al. Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma. Oncotarget. 2012;3:314-326.
84. Cacho-Valadez B, Munoz-Lobato F, Pedrajas JR, et al. The characterization of the Caenorhabditis elegans mitochondrial thioredoxin system uncovers an unexpected protective role of thioredoxin reductase 2 in β-amyloid peptide toxicity. Antioxid Redox Signal. 2012;16:1384-1400.
85. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 1992;20:3821-3830.
86. Nakamura H, De Rosa SC, Yodoi J, et al. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci USA. 2001;98:2688-2693.
87. Baker A, Payne CM, Briehl MM, Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res. 1997;57:5162-5167.
88. Chen Y, Cai J, Murphy TJ, Jones DP. Overexpressed human mitochondrial thioredoxin confers resistance to oxidantinduced apoptosis in human osteosarcoma cells. J Biol Chem. 2002;277:33242-33248.
89. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, et al. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 2002;21:1695-1703.
90. Waxman DJ, O, Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol. 2006;20:2613-2629.
91. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol toxicol. 2007;47:89-116.
92. Sharma S, Rakoczy S, Dahlheimer K, Brown-Borg H. The hippocampus of Ames dwarf mice exhibits enhanced antioxidative defenses following kainic acid-induced oxidative stress. Exp Gerontol. 2010;45:936-949.
93. Leiser SF, Miller RA. Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice. Mol Cell Biol. 2010;30:871-884.
94. Sun LY, Bokov AF, Richardson A, Miller RA. Hepatic response to oxidative injury in long-lived Ames dwarf mice. fASEB J. 2011;25:398-408.
95. Chanas SA, Jiang Q, McMahon M, et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J. 2002;365(Pt 2):405-416.
96. Harvey CJ, Thimmulappa RK, Singh A, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress.free Radic Biol Med. 2009;46:443-453.
97. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liverspecific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:313-329.
98. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci. 2012;67:599-610.
99. Ungvari Z, Gautam T, Koncz P, et al. Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A Biol Sci Med Sci. 2010;65:1145-1156.